Loading, please wait ...


News Analytics

qbrexza.
It is our hope that Qbrexza will not only provide the clinical benefit these sufferers have been seeking, but help to reduce the overall burden on their lives.” From the announcement by Dermira: The approval is based on results from two Phase 3 clinical trials, ATMOS-1 and ATMOS-2, which evaluated the efficacy and safety of Qbrexza in patients with primary axillary ...

Subject Matter

  • Healthcare 77.14%
    • Hospitals, doctors and medical care 100.00%
  • Science and technology 22.86%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions